To study the rate of HIV Sero-positivity in paediatric patients with high risk clinical profile

Authors

  • Tarsem Singh Department of Paediatrics, LLRM medical college, Meerut, Uttar Pradesh, India
  • Navreet Kaur Natt Department of Pharmacology, Government Medical College, Amritsar, Punjab, India
  • Sneh Prabha Goel Department of Paediatrics, LLRM Medical College, Meerut, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20182810

Keywords:

Clinical profile, High risk, Pediatric HIV, Seropositivity

Abstract

Background: Understanding the magnitude and clinical profile of pediatric HIV is essential for the clinicians and policy makers. The study was aimed to determine the rate of HIV seropositivity in pediatric patients with high risk clinical profile, study the clinical presentations and the mode of transmission of HIV in children.

Methods: This prospective hospital-based study to screen 244 children aged 18 months to 12 years with high risk clinical profile for HIV seropositivity was carried out for a period of 1 year.

Results: Of the 244 children screened, the commonest clinical features associated with high risk profile were failure to thrive in 200 (81.97%), persistent fever in 151 (61.89%), chronic diarrhoea in 76 (31.15%), cough >1month 112 (45.90%) patients. HIV seropositivity was reported in 11/244 (4.51%) patients; with failure to thrive in 10/11 (90.90%), chronic diarrhoea in 09/11 (81.81%), seborrheic dermatitis in 2/11 (18.18%) patients followed by persistent cough, severe malnutrition, oral thrush, generalized lymphadenopathy and recurrent bacterial skin infections in 1 patient each out of 11(9.09%). Chronic diarrhoea was a significant independent clinical risk factor for predicting HIV seropositivity (Chi2 = 13.81, p<0.001, Odds ratio=11.15). The probability of HIV seropositivity increased significantly with the number of risk factors concomitantly present, with 30% seropositivity in those with four clinical risk factors (Chi2 =32.89, D. F=1, P<0.001). The parents of all seropositive children were seropositive.

Conclusions: The probability of HIV infection in a child depends upon the nature and number of clinical manifestations present. All HIV positive children h HIV positive parents in this study indicating vertical transmission.

References

UNAIDS. Together we will end AIDS. Geneva, UNAIDS, 2012. Available at: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/20120718_togetherwewillendaids_en.pdf.

Newell ML, Brahmbhatt H, Ghys PD. Child mortality and HIV infection in Africa: a review. AIDS. 2004;18(suppl 2):S27-S34.

Esamai F, Buku GM. HIV seropositivity in children admitted with diarrhea at Eldoret District Hospital, Kenya. E Afr Med J. 1994;71:631-4.

Lepage P, Van de Perre P, Nsengumuremye F, Van Goethem C, Bogaerts J, Hitimana LG. Bacteremia as predictor of HIV infection in African children. Acta Paediatr Scand. 1989;78:763-6.

Pallangyo K, Hakanson A, Lema L, Arris E, Mteza I, Palsson K, et al. High HIV seroprevalence and increased HIC associated mortality among hospitalized patients with bacterial infections in Dar es Salaam, Tanzania. AIDS. 1992,6:971-6.

Matee MLN, Lyamuya EF, Mwinula JH, Mbena EC, Samaranayke LP, Scheutz FF. Clinical predictors of HIV-1 infection among preschool children in Dar es Salaam, Tanzania. East Afr Med J. 1995;72:694-8.

Karande S, Bhalke S, Kelkar A, Ahuja S, Kulkarni M, Mathur M. Utility of Clinical Directed Selective Screening to diagnose HIV infection on hospitalized children in Bombay, Indian J Trop Pediatr. 2002;48:149-55.

Bavedkar BS and Agarwal R. Clinical Directed Selective Screening to diagnose HIV infection on hospitalized children in Mumbai, India. J Trop Pediatr. 2005;42:1191-7.

Shahab T, Zona MS, Malik MA, Malik A, Afzal K. Prevalence of HIV infection in children with tuberculosis. Indian J tropical Pediatr. 2004;41:595-9.

ICMR. Bulletin 1997. 1997;12:117-126.

WHO. Antiretroviral therapy of HIV infection in resource limited setting, towards universal access: Recommendations for a public health approach (2006 revision). WHO, 2006.

NACO and Indian Academy of paediatrics. Guidelines for HIV care and treatment in Infants and children. 2006. Available at: http://apps.who.int/medicinedocs/documents/s18022en/s18022en.pdf.

National AIDS Control Organization. Specialists training and reference module. 2001;49-66.

Dandona R, Kumar SGP, Kumar GA, Lakshmi V, Dandona L. HIV testing among adults in a high prevalence district in India. National Medical J India. 2009;22(6):289-93.

Shah NK, Mehta K, Manglani MV. Prevention of mother to child transmission of HIV. Indian J Pract Pediatric. 2003;4:337-47.

Behrman RE, Kliegman RM, Henson HB. Acquired Immunodeficiency Syndrome. In: Nelson Textbook of Pediatrics ed. 2007. Edn Yogdev R, Chadwick EG. 2007:1109-1120.

Myers G, Korber B, Berzofsky JA, Smith RF, Pavlakis GN: Human Retroviruses and AIDS 1993: A complication and Analysis of nucleic acid and Amino Acid Sequences. Loa Alamos: Los Alamos National Laboratory, 1993.

WHO, UNAIDS, UNICEF. Report on the global AIDS epidemic 2010. Geneva, WHO, 2010. Available at: http://www.unaids.org/globalreport/ documents/20101123_GlobalReport_full_en.pdf. Accessed on 8 November 2011.

Downloads

Published

2018-06-25

How to Cite

Singh, T., Natt, N. K., & Goel, S. P. (2018). To study the rate of HIV Sero-positivity in paediatric patients with high risk clinical profile. International Journal of Research in Medical Sciences, 6(7), 2318–2323. https://doi.org/10.18203/2320-6012.ijrms20182810

Issue

Section

Original Research Articles